Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 84 of 215 for:    Inflammatory Myopathies

Enhanced External Counterpulsation on Delayed Onset Muscle Soreness

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02175316
Recruitment Status : Completed
First Posted : June 26, 2014
Last Update Posted : September 11, 2017
Sponsor:
Information provided by (Responsible Party):
David Grant U.S. Air Force Medical Center

Brief Summary:
This study will evaluate the effects of Enhanced External Counterpulsation on delayed onset muscle soreness. The primary outcomes will be duration of delayed onset muscle soreness, WBC count, CRP count, CPK count, and pain tolerance.

Condition or disease Intervention/treatment Phase
Muscle Tightness Device: Enhanced External Counterpulsation Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 18 participants
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Prevention
Official Title: Effects of Enhanced External Counterpulsation on Delayed Onset Muscle Soreness, a Pilot Study
Study Start Date : April 2014
Actual Primary Completion Date : July 25, 2017
Actual Study Completion Date : September 6, 2017

Arm Intervention/treatment
Experimental: Experimental: EECP for DOMS
All enrolled subjects will receive EECP treatment Delayed Onset Muscle Soreness.
Device: Enhanced External Counterpulsation
Enhanced External Counterpulsation
Other Name: Lumenair Enhanced External Counterpulsation Therapy System, Vasomedical




Primary Outcome Measures :
  1. Change in delayed onset muscle soreness over time. [ Time Frame: At 3, 6, 9, 12, 15, 21, 24, 27, 30, 33, 36, 39, 42, 45, 48 Hours ]
    Likert pain surveys


Secondary Outcome Measures :
  1. Pain tolerance [ Time Frame: Baseline, 24 hours, 2 days 3 days 4 days 33 days ]
    Pain tolerance measured by mmHg pressure required to elicit a delayed-onset muscle pain response.

  2. Bio-markers for muscle inflammation [ Time Frame: Baseline, 24 hours, 2 days 3 days 4 days 33 days ]
    Bio-markers for muscle inflammation: C-reactive protein, creatine phosphokinase, and white blood cell count.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   25 Years to 59 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Healthy active Duty or DoD beneficiaries between 25 and 59 years old

Exclusion Criteria:

  • Not on a physical profile
  • Not taking any OTC or prescription pain medications or workout supplements

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02175316


Locations
Layout table for location information
United States, California
David Grant USAF Medical Center
Travis Air Force Base, California, United States, 94535
Sponsors and Collaborators
David Grant U.S. Air Force Medical Center
Investigators
Layout table for investigator information
Principal Investigator: Sachin Shah United States Air Force

Layout table for additonal information
Responsible Party: David Grant U.S. Air Force Medical Center
ClinicalTrials.gov Identifier: NCT02175316     History of Changes
Other Study ID Numbers: FDG20130045H
First Posted: June 26, 2014    Key Record Dates
Last Update Posted: September 11, 2017
Last Verified: September 2017

Additional relevant MeSH terms:
Layout table for MeSH terms
Myalgia
Muscular Diseases
Musculoskeletal Diseases
Neuromuscular Diseases
Nervous System Diseases
Musculoskeletal Pain
Pain
Neurologic Manifestations
Signs and Symptoms